The Centers for Medicare & Medicaid Services today announced refinements to the Medicare Advantage Valued-Based Insurance Design Model for calendar year 2019, the third year of the demonstration program. The model is designed to test whether giving MA plans flexibility to offer supplemental benefits or reduced cost sharing to targeted groups of enrollees with certain chronic conditions improves health outcomes and reduces costs. It began this year in Arizona, Indiana, Iowa, Massachusetts, Oregon, Pennsylvania and Tennessee. MA plans in Alabama, Michigan and Texas will join the model in January 2018, and plans in 15 more states can apply to participate in January 2019: California, Colorado, Florida, Georgia, Hawaii, Maine, Minnesota, Montana, New Jersey, New Mexico, North Carolina, North Dakota, South Dakota, Virginia and West Virginia. For 2019, CMS will allow chronic condition special needs plans to participate, and allow participants to propose their own systems or methods for identifying eligible enrollees. Plans must apply or reapply by Jan. 26, 2018 to participate in the model in 2019. For more information, visit http://innovation.cms.gov/initiatives/VBID

Related News Articles

Headline
The National Health Law Program and other groups yesterday filed a class action lawsuit against the Department of Health and Human Services for approving a…
Headline
The three medications approved by the Food and Drug Administration to treat opioid use disorder — methadone, buprenorphine and extended-release naltrexone —…
Headline
Hospitals in states that impose Medicaid work requirements could see reduced Medicaid revenues and operating margins and increased uncompensated care costs,…
Headline
About 34 percent of uninsured U.S. adults did not take their medication as prescribed in 2017 in order to reduce their prescription drug costs, according to a…
Headline
The Medicare Payment Advisory Commission Friday released its March report to Congress.
Headline
In a study of Blue Cross and Blue Shield enrollees reported last week in the New England Journal of Medicine, initial opioid prescriptions declined 54 percent…